The combination immunotherapy affected distant metastases in addition to the treated tumors. It increased the sensitivity of melanomas to checkpoint inhibitors and decreased the creation of new metastases, hence reducing malignant relapses.
Immunotherapy
To increase the efficacy of treatment, scientists from Virginia Tech’s College of Engineering have created a novel cancer immunotherapy that targets cancer-killing cytokines where they are found in tumours.
Novel immunotherapies like CAR T-cell therapies may not be effective in treating aggressive types of blood cancer due to a unique mutation in the cancer cells.
